Screening for Metastatic Osteosarcoma Biomarkers with a DNA Microarray
Authors:
- Hong-Bing GuoHGHong-Bing Guo
- Yu-Rong OuyangYOYu-Rong Ouyang
- Han-Cong ZhangHZHan-Cong Zhang
- Li-Hong LiuLLLi-Hong Liu
- Jie BuJBJie Bu
- Zhi-Hua WangZWZhi-Hua Wang
- Tao XiaoTXTao Xiao
Open Access
- 28 February 2014
- journal article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 15 (4) , 1817-1822
Abstract
Screening for Metastatic Osteosarcoma Biomarkers with a DNA Microarray Metastatic osteosarcoma;differential gene expression;functional enrichment;miRNA;regulatory network; Objective: The aim of this study was to screen for possible biomarkers of metastatic osteosarcoma (OS) using a DNA microarray. Methods: We downloaded the gene expression profile GSE49003 from Gene Expression Omnibus database, which included 6 gene chips from metastatic and 6 from non-metastatic OS patients. The R package was used to screen and identify differentially expressed genes (DEGs) between metastatic and non-metastatic OS patients. Then we compared the expression of DEGs in the two groups and sub-grouped into up-regulated and down-regulated, followed by functional enrichment analysis using the DAVID system. Subsequently, we constructed an miRNA-DEG regulatory network with the help of WebGestalt software. Results: A total of 323 DEGs, including 134 up-regulated and 189 down-regulated, were screened out. The up-regulated DEGs were enriched in 14 subcategories and most significantly in cytoskeleton organization, while the down-regulated DEGs were prevalent in 13 subcategories, especially wound healing. In addition, we identified two important miRNAs (miR-202 and miR-9) pivotal for OS metastasis, and their relevant genes, CALD1 and STX1A. Conclusions: MiR-202 and miR-9 are potential key factors affecting the metastasis of OS and CALD1 and STX1A may be possible targets beneficial for the treatment of metastatic OS. However, further experimental studies are needed to confirm our results.Keywords
This publication has 37 references indexed in Scilit:
- Decrease of miR-202-3p Expression, a Novel Tumor Suppressor, in Gastric CancerPLOS ONE, 2013
- miRNA Signatures Associate with Pathogenesis and Progression of OsteosarcomaCancer Research, 2012
- miR-20a Encoded by the miR-17–92 Cluster Increases the Metastatic Potential of Osteosarcoma Cells by Regulating Fas ExpressionCancer Research, 2012
- WebGestalt2: an updated and expanded version of the Web-based Gene Set Analysis ToolkitBMC Bioinformatics, 2010
- miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasisNature Cell Biology, 2010
- Myc-modulated miR-9 makes more metastasesNature Cell Biology, 2010
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- microRNAs as oncogenes and tumor suppressorsDevelopmental Biology, 2007
- Regulation of Microfilament Organization by Kaposi Sarcoma-associated Herpes Virus-cyclin·CDK6 Phosphorylation of CaldesmonJournal of Biological Chemistry, 2005
- The actin cytoskeleton-associated protein zyxin acts as a tumor suppressor in Ewing tumor cellsExperimental Cell Research, 2005